Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- SEMINAR
July 10, 2006
- Generic Marketing Companies Asked to Cooperate in Follow-up Market Price Surveys
July 10, 2006
- Bayer to Sell Diagnostics Business to Siemens
July 10, 2006
- TOPIC an article
July 10, 2006
- MEDICAL DEVICES/DIAGNOSTICS NEWS IN BRIEF
July 10, 2006
- METI Proposes "Economic Growth Strategy Framework"
July 10, 2006
- NEW PRODUCTS
July 10, 2006
- Council Proposes Cuts of \11.4-14.3 Tril. Over Next 5 Years
July 10, 2006
- SEMINAR
July 10, 2006
- Otsuka's Mozavaptan Recommended for Approval
July 10, 2006
- Asahi Kasei Licenses Fasudil to CoTherix
July 10, 2006
- Proposed Vision Calls For Support of Vaccine Development
July 10, 2006
- SURVEY 2 articles
July 10, 2006
- HPB Sets Up Another Study Group to Promote Clinical Trials
July 10, 2006
- SURVEY 3 articles
July 3, 2006
- Generic Makers Concerned about Extension of Data Protection Period: IGPA Conference
July 3, 2006
- Epadel, Atelec Continue to Drive Mochida's Business
July 3, 2006
- 66th Annual Scientific Sessions of the American Diabetes Association
July 3, 2006
- Blopress Retained Rank as Top-selling Drug in FY2005
July 3, 2006
- Pediatric Clinical Trial of Ketek Temporarily Discontinued in US: sanofi-aventis
July 3, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…